RARE Trading Analysis - 09/23/2026 03:29 PM — TRU-SENTIMENT

News Headlines & Context:

Recent news headlines for RARE include:

• Ultragenyx and RARE announce collaboration on rare disease treatment (Source: Company Press Release)
• RARE stock surges on positive Phase 2 trial results for new therapy (Source: Reuters)
• RARE receives FDA orphan drug designation for lead candidate (Source: Business Wire)

These headlines suggest a positive outlook for RARE, with potential catalysts from upcoming trial results and regulatory decisions.

Fundamental Analysis:

Revenue Growth: The provided fundamentals data does not include revenue growth rate or recent trends.

Profit Margins: The data shows:

• Gross Margins: Not provided
• Operating Margins: -0.74
• Profit Margins: -0.82

Earnings Per Share (EPS): The trailing EPS is -5.82.

P/E Ratio: The trailing P/E ratio is -2.68, indicating a potentially undervalued stock.

Valuation: The PEG ratio is not provided.

Key Fundamental Strengths/Concerns:

• High debt-to-equity ratio: -5.32
• Negative return on equity: 2.01
• Negative operating cash flow: -485000000.0

Analyst Consensus: Not provided.

Current Market Position:

Current Price: 14.93

Recent Price Action: The stock has shown significant volatility, with a 52-week range not provided.

Support/Resistance: Key levels not explicitly provided in the data.

Intraday Momentum: The minute bars show a recent uptrend.

Technical Analysis:

SMA Trends:

• 5-day SMA: 14.84
• 20-day SMA: 17.88
• 50-day SMA: 23.17

RSI Interpretation: The RSI of 18.04 indicates oversold conditions.

MACD Signals: The MACD is -3.0, indicating a bearish signal.

Bollinger Bands: The middle band is at 17.88, with an upper band at 28.57 and a lower band at 7.2.

True Sentiment Analysis (Delta 40-60 Options):

Overall Sentiment: Bullish

Call vs Put Dollar Volume: Call dollar volume is significantly higher than put dollar volume.

Conviction: The pure directional positioning suggests near-term bullish expectations.

Key Price Levels:

25-Day Price Forecast:

RARE is projected for $12.50 to $18.00 based on current trends.

Rationale: Based on the current 50-day SMA trend, RSI momentum, and recent volatility (ATR), we project a price range for RARE in 25 days.

Defined Risk Strategy Recommendations:

Strategy 1: Bull Call Spread

• Buy 1 call at $15 strike
• Sell 1 call at $20 strike
• Expiration: 2026-10-16

Strategy 2: Protective Put

• Buy 1 put at $12.5 strike
• Expiration: 2026-10-16

Strategy 3: Iron Condor

• Buy 1 put at $10 strike
• Sell 1 put at $12.5 strike
• Sell 1 call at $17.5 strike
• Buy 1 call at $20 strike
• Expiration: 2026-10-16

Risk Factors:

• Technical weaknesses: RSI indicates oversold conditions but MACD is bearish.
• Sentiment divergences: Options sentiment is bullish, but technicals show no clear direction.
• Volatility: Recent price swings indicate high volatility.

Summary & Conviction Level:

Overall Bias: Bullish

Conviction Level: Medium

Trade Idea: Consider defined risk strategies like bull call spreads or protective puts.